Secukinumab’s antipsoriatic effects confirmed in U.S. patient populationApril 25, 2022Psoriatic ArthritisPsoriasis
Cupping in dermatologyApril 19, 2022Aesthetic DermatologyPsoriasisAtopic DermatitisInfectious DiseasesUrticariaAcne
Apremilast has neutral effect on vascular inflammation in psoriasis studyApril 8, 2022PsoriasisPsoriatic ArthritisMixed Topics
CV risk biomarkers tentatively identified in psoriatic diseaseMarch 11, 2022Psoriatic ArthritisPsoriasis
Drug survival study looks at what lasts longest in RA, axSpA, PsA, and psoriasisMarch 11, 2022Psoriatic ArthritisPsoriasis
One-third of psoriatic arthritis patients could have metabolic syndrome, data analysis findsMarch 4, 2022Psoriatic ArthritisPsoriasisMixed Topics
How to make the most of your time with psoriasis patientsFebruary 9, 2022PsoriasisPsoriatic Arthritis
A dermatologist-led model for CVD prevention in psoriasis may be feasibleFebruary 1, 2022PsoriasisPsoriatic Arthritis
More frequent secukinumab dosing found to benefit overweight psoriasis patientsJanuary 26, 2022PsoriasisPsoriatic ArthritisMixed Topics
Proactive infliximab monitoring found best for sustaining control of inflammatory diseasesJanuary 10, 2022Psoriatic ArthritisPsoriasis
Case series show no consensus on treatment for palmoplantar pustulosis, generalized pustular psoriasisJanuary 4, 2022PsoriasisRare DiseasesPsoriatic Arthritis
Spesolimab speeds lesion clearance in generalized pustular psoriasisDecember 27, 2021PsoriasisRare DiseasesPsoriatic ArthritisInfectious Diseases
New option for flares in pustular psoriasisDecember 17, 2021PsoriasisRare DiseasesPsoriatic Arthritis
